scholarly journals Gut-sparing treatment of urinary tract infection in patients at high risk ofClostridium difficileinfection

2016 ◽  
Vol 72 (2) ◽  
pp. 522-528 ◽  
Author(s):  
Christopher Staley ◽  
Byron P. Vaughn ◽  
Carolyn T. Graiziger ◽  
Michael J. Sadowsky ◽  
Alexander Khoruts
2015 ◽  
Vol 7 (19) ◽  
pp. 7961-7975 ◽  
Author(s):  
H. Karlsen ◽  
T. Dong

Supplementary urinary tract infection biomarkers might help to improve the performance and reliability of urine test strips for high risk groups.


2018 ◽  
Vol 10 (10) ◽  
pp. 283-293 ◽  
Author(s):  
Ivy Y. Ge ◽  
Helene B. Fevrier ◽  
Carol Conell ◽  
Malika N. Kheraj ◽  
Alexander C. Flint ◽  
...  

Background: Risk of community-acquired Clostridium difficile infection (CA-CDI) following antibiotic treatment specifically for urinary tract infection (UTI) has not been evaluated. Methods: We conducted a nested case-control study at Kaiser Permanente Northern California, 2007–2010, to assess antibiotic prescribing and other factors in relation to risk of CA-CDI in outpatients with uncomplicated UTI. Cases were diagnosed with CA-CDI within 90 days of antibiotic use. We used matched controls and confirmed case-control eligibility through chart review. Antibiotics were classified as ciprofloxacin (most common), or low risk (nitrofurantoin, sulfamethoxazole/trimethoprim), moderate risk, or high risk (e.g. cefpodoxime, ceftriaxone, clindamycin) for CDI. We computed the adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the relationship of antibiotic treatment for uncomplicated UTI and history of relevant gastrointestinal comorbidity (including gastrointestinal diagnoses, procedures, and gastric acid suppression treatment) with risk of CA-CDI using logistic regression analysis. Results: Despite the large population, only 68 cases were confirmed with CA-CDI for comparison with 112 controls. Female sex [81% of controls, adjusted odds ratio (OR) 6.3, CI 1.7–24), past gastrointestinal comorbidity (prevalence 39%, OR 2.3, CI 1.1–4.8), and nongastrointestinal comorbidity (prevalence 6%, OR 2.8, CI 1.4–5.6) were associated with increased CA-CDI risk. Compared with low-risk antibiotic, the adjusted ORs for antibiotic groups were as follows: ciprofloxacin, 2.7 (CI 1.0–7.2); moderate-risk antibiotics, 3.6 (CI 1.2–11); and high-risk antibiotics, 11.2 (CI 2.4–52). Conclusions: Lower-risk antibiotics should be used for UTI whenever possible, particularly in patients with a gastrointestinal comorbidity. However, UTI can be managed through alternative approaches. Research into the primary prevention of UTI is urgently needed.


Author(s):  
Erica Freire de Vasconcelos-Pereira ◽  
Ernesto Antonio Figueiró-Filho ◽  
Vanessa Marcon de Oliveira ◽  
Ana Cláudia Oliveira Fernandes ◽  
Clícia Santos de Moura Fé ◽  
...  

2017 ◽  
Vol 50 (4) ◽  
pp. 464-470 ◽  
Author(s):  
Chih-Cheng Lai ◽  
Chun-Ming Lee ◽  
Hsiu-Tzy Chiang ◽  
Ching-Tzu Hung ◽  
Ying-Chun Chen ◽  
...  

PEDIATRICS ◽  
1978 ◽  
Vol 62 (4) ◽  
pp. 521-523
Author(s):  
Mustapha Maherzi ◽  
Jean-Pierre Guignard ◽  
Antonio Torrado

The prevalence of neonatal urinary tract infection (UTI) was studied in 1,762 high-risk neonates. Symptomatic bacteriuria was found in 1.9% and asymptomatic bacteriuria in 0.5% of these neonates. Male preponderance was 5:1. Clinical manifestations were extremely variable-vomiting, weight loss, and diarrhea being the prominent symptoms. Bacteremia was associated with UTI in six infants. The organisms identified in the urine obtained by suprapubic aspiration were Escherichia coli, Klebsiella, and Proteus. A mixed infection was found in four patients. Roentgenographic examination of the urinary tract showed abnormalities in 44% of the symptomatic patients. It is concluded that symptomatic high-risk newborn infants should be screened for bacteniuria, and that radiological investigations be performed in those with proven infection.


Sign in / Sign up

Export Citation Format

Share Document